Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
Saved in:
| Title: | Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy. |
|---|---|
| Authors: | Barrenäs F; Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden., Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Law L; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America., Driscoll C; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America., Green RR; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America., Smith E; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America., Chang J; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America., Golez I; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America., Urion T; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America., Peng X; Department of Molecular Biomedical Sciences and Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, United States of America., Whitmore L; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America., Newhouse D; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America., Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Randall KT; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Selseth AN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Randall BE; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Ainslie E; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Oswald K; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Shoemaker R; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Fast R; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Bosche WJ; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Fukazawa Y; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Pavlakis GN; Human Retrovirus Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, United States of America., Felber BK; Human Retrovirus Pathogenesis Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, United States of America., Fourati S; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America., Sekaly RP; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America., Lifson JD; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Komorowski J; Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden., Kosmider E; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Shao D; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Song W; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Gale M Jr; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America. |
| Source: | PLoS pathogens [PLoS Pathog] 2021 Jul 06; Vol. 17 (7), pp. e1009278. Date of Electronic Publication: 2021 Jul 06 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34228762 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Barrenäs+F%22">Barrenäs F</searchLink>; Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Hansen+SG%22">Hansen SG</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Law+L%22">Law L</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Driscoll+C%22">Driscoll C</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Green+RR%22">Green RR</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Smith+E%22">Smith E</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Chang+J%22">Chang J</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Golez+I%22">Golez I</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Urion+T%22">Urion T</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Peng+X%22">Peng X</searchLink>; Department of Molecular Biomedical Sciences and Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Whitmore+L%22">Whitmore L</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Newhouse+D%22">Newhouse D</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Hughes+CM%22">Hughes CM</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Morrow+D%22">Morrow D</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Randall+KT%22">Randall KT</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Selseth+AN%22">Selseth AN</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Ford+JC%22">Ford JC</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Gilbride+RM%22">Gilbride RM</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Randall+BE%22">Randall BE</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Ainslie+E%22">Ainslie E</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Oswald+K%22">Oswald K</searchLink>; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Shoemaker+R%22">Shoemaker R</searchLink>; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Fast+R%22">Fast R</searchLink>; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Bosche+WJ%22">Bosche WJ</searchLink>; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Axthelm+MK%22">Axthelm MK</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Fukazawa+Y%22">Fukazawa Y</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Pavlakis+GN%22">Pavlakis GN</searchLink>; Human Retrovirus Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Felber+BK%22">Felber BK</searchLink>; Human Retrovirus Pathogenesis Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Fourati+S%22">Fourati S</searchLink>; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.<br /><searchLink fieldCode="AU" term="%22Sekaly+RP%22">Sekaly RP</searchLink>; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America.<br /><searchLink fieldCode="AU" term="%22Lifson+JD%22">Lifson JD</searchLink>; AIDS and Cancer Virus Program, SAIC Frederick, Inc., Frederick National Laboratory, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Komorowski+J%22">Komorowski J</searchLink>; Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Kosmider+E%22">Kosmider E</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Shao+D%22">Shao D</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Song+W%22">Song W</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Edlefsen+PT%22">Edlefsen PT</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Picker+LJ%22">Picker LJ</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Gale+M+Jr%22">Gale M Jr</searchLink>; Center for Innate Immunity and Immune Disease, Department of Immunology, University of Washington, Seattle, Washington, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2021 Jul 06; Vol. 17 (7), pp. e1009278. <i>Date of Electronic Publication: </i>2021 Jul 06 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34228762 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.ppat.1009278 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1009278 Titles: – TitleFull: Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Barrenäs F – PersonEntity: Name: NameFull: Hansen SG – PersonEntity: Name: NameFull: Law L – PersonEntity: Name: NameFull: Driscoll C – PersonEntity: Name: NameFull: Green RR – PersonEntity: Name: NameFull: Smith E – PersonEntity: Name: NameFull: Chang J – PersonEntity: Name: NameFull: Golez I – PersonEntity: Name: NameFull: Urion T – PersonEntity: Name: NameFull: Peng X – PersonEntity: Name: NameFull: Whitmore L – PersonEntity: Name: NameFull: Newhouse D – PersonEntity: Name: NameFull: Hughes CM – PersonEntity: Name: NameFull: Morrow D – PersonEntity: Name: NameFull: Randall KT – PersonEntity: Name: NameFull: Selseth AN – PersonEntity: Name: NameFull: Ford JC – PersonEntity: Name: NameFull: Gilbride RM – PersonEntity: Name: NameFull: Randall BE – PersonEntity: Name: NameFull: Ainslie E – PersonEntity: Name: NameFull: Oswald K – PersonEntity: Name: NameFull: Shoemaker R – PersonEntity: Name: NameFull: Fast R – PersonEntity: Name: NameFull: Bosche WJ – PersonEntity: Name: NameFull: Axthelm MK – PersonEntity: Name: NameFull: Fukazawa Y – PersonEntity: Name: NameFull: Pavlakis GN – PersonEntity: Name: NameFull: Felber BK – PersonEntity: Name: NameFull: Fourati S – PersonEntity: Name: NameFull: Sekaly RP – PersonEntity: Name: NameFull: Lifson JD – PersonEntity: Name: NameFull: Komorowski J – PersonEntity: Name: NameFull: Kosmider E – PersonEntity: Name: NameFull: Shao D – PersonEntity: Name: NameFull: Song W – PersonEntity: Name: NameFull: Edlefsen PT – PersonEntity: Name: NameFull: Picker LJ – PersonEntity: Name: NameFull: Gale M Jr IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 07 Text: 2021 Jul 06 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1553-7374 Numbering: – Type: volume Value: 17 – Type: issue Value: 7 Titles: – TitleFull: PLoS pathogens Type: main |
| ResultId | 1 |